Oral Oncology
Volume 38, Issue 8 , Pages 800-805, December 2002

Odontoameloblastoma. Clinico-pathologic study of three cases and critical review of the literature

  • Adalberto Mosqueda-Taylor

      Affiliations

    • Departamento de Atención a la Salud, Universidad Autónoma Metropolitana Xochimilco, Calzado del Hueso 1100, Col. Villa Quietud, Mexico, DF 04960
    • Corresponding Author InformationCorresponding author. Tel./fax: +52-54-83-72-06
  • ,
  • Roman Carlos-Bregni

      Affiliations

    • Departamento de Patologı́a, Hospital Herrera-Llerandi, AMEDESGUA, Guatemala City, Guatemala
  • ,
  • Velia Ramı́rez-Amador

      Affiliations

    • Departamento de Atención a la Salud, Universidad Autónoma Metropolitana Xochimilco, Calzado del Hueso 1100, Col. Villa Quietud, Mexico, DF 04960
  • ,
  • José Mario Palma-Guzmán

      Affiliations

    • Facultad de Estomatologı́a, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
  • ,
  • Daniel Esquivel-Bonilla

      Affiliations

    • Servicio de Cirugı́a Oral y Maxilofacial, Hospital General de Puebla “Dr. Eduardo Vázquez Navarro”, Puebla, Mexico
  • ,
  • Luis Angel Hernández-Rojas

      Affiliations

    • Departamento de Cirugı́a Bucomaxilofacial, Hospital General San Juan de Dios, Guatemala City, Guatemala

Received 20 May 2002; accepted 14 June 2002.

Abstract 

The odontoameloblastoma (OA), is an infrequent neoplasm. To date, there are less than 50 cases reported as OA or ameloblastic odontoma in the English dental literature, but only 14 (including three of our own material), fulfill the histological criteria of the current WHO histological classification of odontogenic tumours. Nine occurred in men and five in women (male to female ratio 1.8:1). Age ranged from 2 to 50 years (mean 20.2 years), and nine cases (64.2%) were diagnosed during the first two decades. Maxilla and mandible were equally involved, and most cases occurred posterior to the canines (71.4%). Follow-up ranged from 6 months to 8 years (mean: 25.5 months). Of the 12 cases with informed follow-up, two recurred once (at 24 and 18 months, respectively), and one case had two documented recurrences, at 6 and 49 months. Although OA tends to occur at an earlier age than conventional ameloblastoma, it has practically the same potential to produce bone expansion, root resorption and recurrence. For these reasons OA should be treated in a similar fashion, with wide surgical excision and close follow-up for at least 5 years.

Keywords:  Odontogenic tumours, Ameloblastoma, Odontoma, Odontoameloblastoma, Mixed odontogenic tumours

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(02)00046-5

doi:10.1016/S1368-8375(02)00046-5

Oral Oncology
Volume 38, Issue 8 , Pages 800-805, December 2002